Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 24 May 2012 |
| Daratumumab Clinical Data to Be Presented at ASCO and EHA | 17 May 2012 |
| Genmab Announces Financial Results for the First Quarter 2012 | 15 May 2012 |
| Articles of Association of Genmab A/S | 8 May 2012 |
| New Drug Application for Arzerra Submitted in Japan | 27 Apr 2012 |